A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Clinical trial NCT06585696 · COMPLETED

Trial details

NCT number: NCT06585696
Sponsor: Cutia Therapeutics（Wuxi）Co.,Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glabellar Frown Lines

Start date: 2024-06-24
Primary completion: 2025-11-20
Enrollment: 554

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.